Jacob Donoghue

Beacon Biosignals, Inc. is a company that provides a machine learning platform for EEG to enable and accelerate new treatments for patients with neurological, psychiatric, or sleep disorders. The company is based in Boston, MA and has subsidiaries in France. The company uses novel machine learning algorithms, large clinical datasets, and advances in software engineering to empower biopharma companies with unparalleled tools for efficacy monitoring, patient stratification, and clinical trial endpoints from brain data. The company was founded in 2019 by Brandon Westover, Jarrett Revels, Sydney Cash, Jacob A. Donoghue. Jacob A. Donoghue has been the CEO since 2019.

Beacon Biosignals, Inc. is a company that provides a machine learning platform for EEG to enable and accelerate new treatments for patients with neurological, psychiatric, or sleep disorders. The company is based in Boston, MA and has subsidiaries in France. The company uses novel machine learning algorithms, large clinical datasets, and advances in software engineering to empower biopharma companies with unparalleled tools for efficacy monitoring, patient stratification, and clinical trial endpoints from brain data. The company was founded in 2019 by Brandon Westover, Jarrett Revels, Sydney Cash, Jacob A. Donoghue. Jacob A. Donoghue has been the CEO since 2019.

Beacon Biosignals, Inc. is a company that provides a machine learning platform for EEG to enable and accelerate new treatments for patients with neurological, psychiatric, or sleep disorders. The company is based in Boston, MA and has subsidiaries in France. The company uses novel machine learning algorithms, large clinical datasets, and advances in software engineering to empower biopharma companies with unparalleled tools for efficacy monitoring, patient stratification, and clinical trial endpoints from brain data. The company was founded in 2019 by Brandon Westover, Jarrett Revels, Sydney Cash, Jacob A. Donoghue. Jacob A. Donoghue has been the CEO since 2019.

Beacon Biosignals, Inc. is a company that provides a machine learning platform for EEG to enable and accelerate new treatments for patients with neurological, psychiatric, or sleep disorders. The company is based in Boston, MA and has subsidiaries in France. The company uses novel machine learning algorithms, large clinical datasets, and advances in software engineering to empower biopharma companies with unparalleled tools for efficacy monitoring, patient stratification, and clinical trial endpoints from brain data. The company was founded in 2019 by Brandon Westover, Jarrett Revels, Sydney Cash, Jacob A. Donoghue. Jacob A. Donoghue has been the CEO since 2019.

Beacon Biosignals, Inc. is a company that provides a machine learning platform for EEG to enable and accelerate new treatments for patients with neurological, psychiatric, or sleep disorders. The company is based in Boston, MA and has subsidiaries in France. The company uses novel machine learning algorithms, large clinical datasets, and advances in software engineering to empower biopharma companies with unparalleled tools for efficacy monitoring, patient stratification, and clinical trial endpoints from brain data. The company was founded in 2019 by Brandon Westover, Jarrett Revels, Sydney Cash, Jacob A. Donoghue. Jacob A. Donoghue has been the CEO since 2019.